Are you Dr. Aldape?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 54 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Kenneth Aldape, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Washington, and California.
Education & Training
University of California (San Francisco)Fellowship, Neuropathology, 1993 - 1995- University of California (San Francisco) School of MedicineInternship, Transitional Year, 1991 - 1992
- University of California San Francisco School of MedicineClass of 1991
Certifications & Licensure
TX State Medical License 2001 - 2024
CA State Medical License 1992 - 2024
WA State Medical License 2015 - 2018- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.Sheila Mansouri, Suganth Suppiah, Yasin Mamatjan, Irene Paganini, Jeff C. Liu, Shirin Karimi, Vikas Patil, Farshad Nassiri, Olivia Singh, Yogi Sundaravadanam, Prisni R...> ;Acta Neuropathologica. 2021 Jan 1
- 18 citationsEpigenomic, genomic, and transcriptomic landscape of schwannomatosis.Sheila Mansouri, Suganth Suppiah, Yasin Mamatjan, Irene Paganini, Jeff C. Liu, Shirin Karimi, Vikas Patil, Farshad Nassiri, Olivia Singh, Yogi Sundaravadanam, Prisni R...> ;Acta Neuropathologica. 2021 Jan 1
- 21 citationsClinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.Kohei Fukuoka, Yasin Mamatjan, Ruth G. Tatevossian, Michal Zapotocky, Scott Ryall, Ana Guerreiro Stucklin, Julie Bennett, Liana Nobre, Anthony Arnoldo, Betty Luu, Ji W...> ;Neuro-Oncology. 2020 Oct 14
- Join now to see all
Press Mentions
NCI-CONNECT and BTTC 2019 MeetingsJune 3rd, 2019
UHN Research Team Maps Genomic Landscape of Schwannoma TumoursOctober 12th, 2016
Key to New Brain Cancer Therapies?October 19th, 2015- Join now to see all
Grant Support
- Prediction Of Chemoradiation Response In Glioblastoma To Individualize TherapyNational Cancer Institute2008–2011
- Cb: Pathology And Tissue Procurement CoreNational Cancer Institute2008–2011
- Towards A Refined Molecular Recursive Partitioning Analysis Model For GlioblastomNational Cancer Institute2009–2010
